<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591393</url>
  </required_header>
  <id_info>
    <org_study_id>S60939</org_study_id>
    <nct_id>NCT03591393</nct_id>
  </id_info>
  <brief_title>Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function</brief_title>
  <acronym>PFD-BI</acronym>
  <official_title>Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function - A Prospective Study Through Pregnancy and Post-partum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first objective to determinate the prevalence of pelvic floor dysfunction in pregnant
      women and in the first year postpartum. The second objective is to assess the anatomical
      (both clinical and ultrasound), demographic and obstetric variables in symptomatic women and
      their association with pelvic floor dysfunction, sexual function and Body Image.

      This is a single center prospective cohort study. Women will be asked to fill out a
      questionnaire at the time of their 1st and 3rd trimester scan, at the postpartum checkup and
      12 months postpartum. Furthermore, they will undergo a pelvic floor ultrasound at the time of
      their first and third trimester scan.

      The presence of pelvic floor dysfunctions will be recorded through validated
      self-administered questionnaires with five domains: Wexner questionnaire for anal
      incontinence, PAC-SYM for constipation, International Consultation on Incontinence
      Questionnaire Short Form for urinary incontinence, the Pelvic Organ Prolapse Distress
      Inventory for pelvic organ prolapse, POP/UI Sexual Questionnaire - IUGA revised for sexual
      function.

      The body image perception will be assessed using the Dutch-validated version of the
      self-administered Body Image Disturbance Questionnaire.

      The anatomy of the pelvic floor will be objectively assessed off line on 3D/4D transperineal
      ultrasound volumes and POP-Q examination. The demographic variables and information about the
      pregnancy and the delivery will be obtained from the medical records.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change Body Image during and after pregnancy</measure>
    <time_frame>through study completion, an average of 18 months</time_frame>
    <description>Body Image Disturbance Questionnaire Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urethra mobility in cm</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>Transperineal ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urethra mobility in cm</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>Transperineal ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genital hiatus in cm^2</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>Transperineal ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genital hiatus in cm^2</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>Transperineal ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>levator ani avulsion</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>TUI sequence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>levator ani avulsion</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>TUI sequence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anal sphincter injury</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>TUI sequence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anal sphincter injury</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>TUI sequence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Incontinence</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>International Consultation Incontinence Questionnaire - short form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Incontinence</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>International Consultation Incontinence Questionnaire - short form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Incontinence</measure>
    <time_frame>3 months postpartum</time_frame>
    <description>International Consultation Incontinence Questionnaire - short form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Incontinence</measure>
    <time_frame>12 months postpartum</time_frame>
    <description>International Consultation Incontinence Questionnaire - short form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal Incontinence</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>wexner score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal Incontinence</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>wexner score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal Incontinence</measure>
    <time_frame>3 months postpartum</time_frame>
    <description>wexner score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal Incontinence</measure>
    <time_frame>12 months postpartum</time_frame>
    <description>wexner score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>Pelvic Organ Prolapse Distress Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>Pelvic Organ Prolapse Distress Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse</measure>
    <time_frame>3 months postpartum</time_frame>
    <description>Pelvic Organ Prolapse Distress Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse</measure>
    <time_frame>12 months postpartum</time_frame>
    <description>Pelvic Organ Prolapse Distress Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>11-13 weeks gestation</time_frame>
    <description>POP/UI Sexual Questionnaire - IUGA revised</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>28-33 weeks gestation</time_frame>
    <description>POP/UI Sexual Questionnaire - IUGA revised</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>3 months postpartum</time_frame>
    <description>POP/UI Sexual Questionnaire - IUGA revised</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>12 months postpartum</time_frame>
    <description>POP/UI Sexual Questionnaire - IUGA revised</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">622</enrollment>
  <condition>Body Image</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Anal Incontinence</condition>
  <condition>Anorectal Disorder</condition>
  <condition>Constipation</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Sexual Dysfunction</condition>
  <condition>Pregnancy Related</condition>
  <condition>Postpartum Disorder</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>questionnaire at 1st and 3rd trimester, 10-12 weeks postpartum and 12 months postpartum
pelvic floor ultrasound at 1st trimester and at 3rd trimester</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>questionnaire</intervention_name>
    <description>Validated self-administered questionnaires with five domains: Wexner questionnaire for anal incontinence, PAC-SYM for constipation, International Consultation on Incontinence Questionnaire Short Form for urinary incontinence, the Pelvic Organ Prolapse Distress Inventory for pelvic organ prolapse, POP/UI Sexual Questionnaire - IUGA revised for sexual function.
The body image perception will be assessed using the Dutch-validated version of the self-administered Body Image Disturbance Questionnaire.</description>
    <arm_group_label>Pregnant women</arm_group_label>
    <other_name>pelvic floor ultrasound</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; or = 18 years

          -  dutch-speaking

          -  ongoing pregnancy before 14 weeks GA

          -  intending to deliver in UZ Leuven

          -  ICF

        Exclusion Criteria:

          -  age &lt; 18 years

          -  not dutch-speaking

          -  non evolutive pregnancy

          -  pregnancy over 14 weeks GA

          -  intention to deliver elsewhere
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Deprest, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Deprest, MD, PhD</last_name>
    <phone>+3216344269</phone>
    <email>jan.deprest@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leen Mortier</last_name>
    <phone>+3216345123</phone>
    <email>leen.mortier@uzleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Deprest, MD, PhD</last_name>
      <phone>+3216344269</phone>
      <email>jan.deprest@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Leen Mortier</last_name>
      <phone>+3216345123</phone>
      <email>leen.mortier@uzleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Jan Deprest, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Cattani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <results_reference>
    <citation>Lagaert L, Weyers S, Van Kerrebroeck H, Elaut E. Postpartum dyspareunia and sexual functioning: a prospective cohort study. Eur J Contracept Reprod Health Care. 2017 Jun;22(3):200-206. doi: 10.1080/13625187.2017.1315938. Epub 2017 Apr 27.</citation>
    <PMID>28447919</PMID>
  </results_reference>
  <results_reference>
    <citation>Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798. Review.</citation>
    <PMID>19941278</PMID>
  </results_reference>
  <results_reference>
    <citation>Reimers C, Staer-Jensen J, Siafarikas F, Saltyte-Benth J, Bø K, Ellström Engh M. Change in pelvic organ support during pregnancy and the first year postpartum: a longitudinal study. BJOG. 2016 Apr;123(5):821-9. doi: 10.1111/1471-0528.13432. Epub 2015 Jun 26.</citation>
    <PMID>26113145</PMID>
  </results_reference>
  <results_reference>
    <citation>Skouteris H, Carr R, Wertheim EH, Paxton SJ, Duncombe D. A prospective study of factors that lead to body dissatisfaction during pregnancy. Body Image. 2005 Dec;2(4):347-61. Epub 2005 Nov 21.</citation>
    <PMID>18089200</PMID>
  </results_reference>
  <results_reference>
    <citation>Clark A, Skouteris H, Wertheim EH, Paxton SJ, Milgrom J. The relationship between depression and body dissatisfaction across pregnancy and the postpartum: a prospective study. J Health Psychol. 2009 Jan;14(1):27-35. doi: 10.1177/1359105308097940.</citation>
    <PMID>19129334</PMID>
  </results_reference>
  <results_reference>
    <citation>Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 Jan;36(1):77-97. Review.</citation>
    <PMID>8416784</PMID>
  </results_reference>
  <results_reference>
    <citation>Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999 Sep;34(9):870-7.</citation>
    <PMID>10522604</PMID>
  </results_reference>
  <results_reference>
    <citation>Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322-30.</citation>
    <PMID>15227649</PMID>
  </results_reference>
  <results_reference>
    <citation>Utomo E, Blok BF, Steensma AB, Korfage IJ. Validation of the Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Floor Impact Questionnaire (PFIQ-7) in a Dutch population. Int Urogynecol J. 2014 Apr;25(4):531-44. doi: 10.1007/s00192-013-2263-z. Epub 2014 Jan 21.</citation>
    <PMID>24445668</PMID>
  </results_reference>
  <results_reference>
    <citation>Dietz HP. Pelvic floor ultrasound: a review. Am J Obstet Gynecol. 2010 Apr;202(4):321-34. doi: 10.1016/j.ajog.2009.08.018. Review.</citation>
    <PMID>20350640</PMID>
  </results_reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>July 6, 2018</last_update_submitted>
  <last_update_submitted_qc>July 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Rectal Diseases</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Puerperal Disorders</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

